Fenofibrate (micronized recalls
The FDA has published 3 recalls involving Fenofibrate (micronized since 2016. The latest was reported on 20 Apr 2016. Impax Laboratories has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2016
Last 12 months0reported
Class I00% of total
Ongoing0latest 20 Apr 2016
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 3 100%
Why fenofibrate (micronized is recalled
Companies
By year
All fenofibrate (micronized recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Fenofibrate Capsules (Micronized) 200 mg recalled by Impax Laboratories | Impax Laboratories | Other | Nationwide |
| Drug | CLASS III | Fenofibrate Capsules (Micronized) recalled | Amerisource Health Services | Packaging Defects | Nationwide |
| Drug | CLASS III | Fenofibrate Capsules (Micronized) 134 mg recalled by Impax Laboratories | Impax Laboratories | Other | Nationwide |
Should you stop taking Fenofibrate (micronized?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.